Laser therapy in diabetic patient with neuropathy

Evaluation of LASER therapy in treatment of peripheral neuropathy of diabetic patients referred to Imam Hossein Hospital

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201009048972N1

Enrollment

100

Registered

2021-11-07

Start date

2021-11-11

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral neuropathy in diabetic patients. Type 2 diabetes mellitus with diabetic neuropathy, unspecified

Interventions

Intervention 1: Intervention group: Diabetic patients with peripheral neuropathy who undergo laser therapy with a wavelength between 650 to 810 nm three times a week for twelve sessions and each sessi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic patients Peripheral neuropathy

Exclusion criteria

Exclusion criteria: No willingness to participate in the study; Other neurological diseases; People who underwent laser sessions for the purpose of recent cosmetic surgery.

Design outcomes

Primary

Measure	Time frame
Peripheral neuropathy in diabetic patients. Timepoint: Before and after laser therapy. Method of measurement: Michigan neuropathy screening test and monofilament test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahar Tavakoli

Shahid Beheshti University of Medical Sciences

sahartavakoli44@gmail.com+98 21 3310 1479

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026